Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Riganti

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Anais Brasileiros De Dermatologia|June 12, 2020
Acute generalized exanthematous pustulosis with features mimicking toxic epidermal necrolysis secondary to amiodaroneCheryl Distel, María Luz Bollea Garlatti, Ana Clara Torre, et al.
International Journal of Dermatology|June 22, 2012
Reactivation of Chagas' disease: cutaneous manifestations in two immunosuppressed patientsJulia Riganti, Mariana Guzzi Maqueda, María C Baztán Piñero, et al.
International Journal of Dermatology|December 28, 2023
Beyond guidelines: the high-dose challenge in severe bullous pemphigoid-a hospital perspectiveEry A Ko, Maria I Giustozzi, Ana C Torre, et al.
International Journal of Dermatology|March 8, 2014
Lingual ulceration associated with retinoic acid syndrome during treatment of acute promyelocytic leukemiaJulia Riganti, Mariana P Caviedes, Ana C Torre, et al.
JAAD Case Reports|September 1, 2018
Reticular rash in drug reaction with eosinophilia and systemic symptoms syndrome: A clue to parvovirus B19 reactivation?María Julia Cura, Ana Clara Torre, Karen Yoselin Cueto Sarmiento, et al.
Journal of the American Academy of Dermatology|September 24, 2022
Clinical characterization and treatment outcomes of follicular cutaneous immune-related adverse events caused by immune checkpoint inhibitors: A multicenter retrospective studyAzael Freites-Martinez, Vasiliki Nikolaou, Konstantinos Lallas, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2025
Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and SurvivorsDaniel Alcalá Pérez, Ana Sofia Acosta Madiedo, Sebastian Andreani, et al.
JAMA Dermatology|April 9, 2025
Immune Checkpoint Inhibitor-Induced LipodystrophyJulia Riganti, Ana C Torre, Pietro Sollena, et al.
Journal of the American Academy of Dermatology|December 6, 2020
Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) groupVasiliki Nikolaou, Vincent Sibaud, Davide Fattore, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 3, 2025
Erosive pustular dermatosis of the scalp due to EGFR inhibitors: A multicentric study by EADV task force of 'Dermatology for Cancer Patients'Michela Starace, Luca Rapparini, Stephano Cedirian, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Anais Brasileiros De Dermatologia|June 12, 2020
Acute generalized exanthematous pustulosis with features mimicking toxic epidermal necrolysis secondary to amiodaroneCheryl Distel, María Luz Bollea Garlatti, Ana Clara Torre, et al.
International Journal of Dermatology|June 22, 2012
Reactivation of Chagas' disease: cutaneous manifestations in two immunosuppressed patientsJulia Riganti, Mariana Guzzi Maqueda, María C Baztán Piñero, et al.
International Journal of Dermatology|December 28, 2023
Beyond guidelines: the high-dose challenge in severe bullous pemphigoid-a hospital perspectiveEry A Ko, Maria I Giustozzi, Ana C Torre, et al.
International Journal of Dermatology|March 8, 2014
Lingual ulceration associated with retinoic acid syndrome during treatment of acute promyelocytic leukemiaJulia Riganti, Mariana P Caviedes, Ana C Torre, et al.
JAAD Case Reports|September 1, 2018
Reticular rash in drug reaction with eosinophilia and systemic symptoms syndrome: A clue to parvovirus B19 reactivation?María Julia Cura, Ana Clara Torre, Karen Yoselin Cueto Sarmiento, et al.
Journal of the American Academy of Dermatology|September 24, 2022
Clinical characterization and treatment outcomes of follicular cutaneous immune-related adverse events caused by immune checkpoint inhibitors: A multicenter retrospective studyAzael Freites-Martinez, Vasiliki Nikolaou, Konstantinos Lallas, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2025
Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and SurvivorsDaniel Alcalá Pérez, Ana Sofia Acosta Madiedo, Sebastian Andreani, et al.
JAMA Dermatology|April 9, 2025
Immune Checkpoint Inhibitor-Induced LipodystrophyJulia Riganti, Ana C Torre, Pietro Sollena, et al.
Journal of the American Academy of Dermatology|December 6, 2020
Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) groupVasiliki Nikolaou, Vincent Sibaud, Davide Fattore, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 3, 2025
Erosive pustular dermatosis of the scalp due to EGFR inhibitors: A multicentric study by EADV task force of 'Dermatology for Cancer Patients'Michela Starace, Luca Rapparini, Stephano Cedirian, et al.
Pageof 2